Pozdravna reč profesora Duška Vulića
Heart and Blood Vessels, 39(1/2020):5
How would you treat: glucagon-like peptide 1 receptor analogue or sodium-glucose cotransporter 2 inhibitor
Heart and Blood Vessels, 39(1/2020):8-10
Risk reduction of atherosclerotic cardiovascular disease
Heart and Blood Vessels, 39(1/2020):11-14
Optimal medical therapy in a patient with a large area of ischemia
Heart and Blood Vessels, 39(1/2020):15-18
A case report of an acute postoperative pulmonary thromboembolism
Heart and Blood Vessels, 39(1/2020):19-22
How should we obtain a precise estimate of cardiovascular risk
Heart and Blood Vessels, 39(1/2020):23-26
Treatment challenges in a very high-risk diabetic patient
Heart and Blood Vessels, 39(1/2020):27-30
Supraventricular tachcycardia practical guide
Heart and Blood Vessels, 39(1/2020):31-35
Cryoballoon catheter ablation of atrial fibrillation
Heart and Blood Vessels, 39(1/2020):37-39
APSTRAKT - How would you treat: glucagon-like peptide 1 receptor analogue or sodium-glucose cotransporter 2 inhibitor
Heart and Blood Vessels, 39(1/2020):8-10
APSTRAKT - Risk reduction of atherosclerotic cardiovascular disease
Heart and Blood Vessels, 39(1/2020):11-14
APSTRAKT - Optimal medical therapy in a patient with a large area of ischemia
Heart and Blood Vessels, 39(1/2020):15-18
APSTRAKT - A case report of an acute postoperative pulmonary Thromboembolism
Heart and Blood Vessels, 39(1/2020):19-22
APSTRAKT - How should we obtain a precise estimate of cardiovascular risk
Heart and Blood Vessels, 39(1/2020):23-26
APSTRAKT - Treatment challenges in a very high-risk diabetic patient
Heart and Blood Vessels, 39(1/2020):27-30
APSTRAKT - Supraventricular tachcycardia practical guide for diagnosis and management
Heart and Blood Vessels, 39(1/2020):31-35
